# Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy

> **NCT01434147** · PHASE2 · COMPLETED · sponsor: **Austrian Breast & Colorectal Cancer Study Group** · enrollment: 25 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **DRUG:** preoperative induction chemotherapy in combination with bevacizumab followed by combined radiochemotherapy with capecitabine

## Key facts

- **NCT ID:** NCT01434147
- **Lead sponsor:** Austrian Breast & Colorectal Cancer Study Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2014-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01434147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01434147, "Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01434147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*